HALO

Halozyme Therapeutics, Inc. News Headlines

$9.46
*  
0.44
4.88%
Get HALO Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading HALO now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
HALO Crosses Above Key Moving Average Level
12/19/2014 11:44:36 AM - BNK Invest


Halozyme Up on Collaboration and Licensing Deal with J&J - Analyst Blog
12/18/2014 6:48:00 PM - Zacks.com


Halozyme Up on Collaboration and Licensing Deal with J&J - Analyst Blog
12/18/2014 6:48:00 AM - Investopedia


BIOD To Report Data Next Month, HALO Shines On Deal News, TTPH Gets Ignited
12/17/2014 11:26:00 PM - RTT News


Can Pfizer’s Cholesterol Drug Catch Up To The Competition?
12/11/2014 7:28:02 AM - Motley Fool


Halozyme Therapeutics To Present At Oppenheimer Conference; Webcast At 1:00 PM
12/10/2014 12:00:00 PM - RTT News


Halozyme Therapeutics - Buy The Drug Delivery Platform And Get A Cancer Drug For Free
12/9/2014 11:56:00 AM - Seeking Alpha


Halozyme Therapeutics To Present At Piper Jaffray Conference; Webcast At 1:00 PM
12/3/2014 12:00:00 PM - RTT News


Halozyme Therapeutics Plunge 12% As Q3 Results Miss Estimates
11/10/2014 8:51:00 PM - RTT News


Halozyme Loss Wider Than Estimate, Revenue Misses; Stock Down 8%
11/10/2014 4:57:00 PM - RTT News


First Week of HALO June 2015 Options Trading
10/27/2014 10:17:03 AM - BNK Invest


Vertex Pharmaceuticals' Kalydeco Wins FDA Panel Backing - Analyst Blog
10/22/2014 4:54:00 PM - Zacks.com


Biogen's Q3 Earnings Top Estimates, View Raised Again - Analyst Blog
10/22/2014 12:10:00 PM - Zacks.com


Actelion Misses Q3 Earnings Expectation, Ups 2014 Guidance - Analyst Blog
10/22/2014 10:40:00 AM - Zacks.com


NewLink-Roche Ink Deal for Oncology Candidate Development - Analyst Blog
10/21/2014 5:05:00 PM - Zacks.com


Amicus Reports Additional Positive Data on Fabry Therapy - Analyst Blog
10/20/2014 5:35:00 PM - Zacks.com


Regeneron Pharmaceuticals (REGN) Jumps: Stock Up 8.5% - Tale of the Tape
10/20/2014 8:39:00 AM - Zacks.com


Ultragenyx Reports Data from Sialic Acid Deficiency Study - Analyst Blog
10/17/2014 4:00:00 PM - Zacks.com


Novavax (NVAX) Moves Up: Stock Adds 10.1% in Session - Tale of the Tape
10/17/2014 8:39:00 AM - Zacks.com


What Falling Estimates & Price Mean for Enzo Biochem (ENZ) - Tale of the Tape
10/17/2014 7:57:00 AM - Zacks.com


Lexicon Pharmaceuticals (LXRX) Jumps: Stock Rises 15.7% - Tale of the Tape
10/17/2014 7:51:00 AM - Zacks.com


MannKind (MNKD) Worth Watching: Stock Gains 12.9% - Tale of the Tape
10/16/2014 8:46:00 AM - Zacks.com


Peregrine Pharmaceuticals (PPHM) Jumps: Stock Rises 10.7% - Tale of the Tape
10/16/2014 8:39:00 AM - Zacks.com


NewLink Genetics (NLNK) Shows Strength: Stock Up 23.7% - Tale of the Tape
10/14/2014 8:46:00 AM - Zacks.com


Prosensa Holding N.V. (RNA) in Focus: Stock up 8.5% - Tale of the Tape
10/14/2014 7:44:00 AM - Zacks.com